Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119274507> ?p ?o ?g. }
- W3119274507 abstract "Abstract Objective To evaluate the efficacy and safety of PLD in treating of in patients who experience epithelial ovarian, fallopian tubal, and peritoneal cancer progression within 12 months after the first-line platinum-based therapy. Methods This was an open-label, single-arm and multicenter clinical trial. The ORR was the interim primary objective, and the DCR, AEs and QOL were the secondary objectives. The impact of factors on efficacy outcomes, the change trend of CA125 and the artificial platinum-free interval were exploratory endpoints. Results Totally, 115 patients were enrolled in this study and included in the ITT population. Moreover, 101 patients were included in the safety population. The median follow-up time was 4 months (IQR 2–6). In the ITT population, the confirmed ORR was 37.4% (95% CI, 28.4–46.4%), and the DCR was 65.2% (95% CI, 56.4–74.1%). The previous response status to platinum-based chemotherapy and baseline CA125 levels were significantly correlated with the ORR. The ORR was significantly higher in patients with a CA125 decrease after the first cycle than in the patients with a CA125 increase. The most common grade 3 or higher AE was hand-foot syndrome (3 [3.0%] of 101 patients). No statistically significant differences existed between the baseline and the postbaseline questionnaires. Conclusions For patients who experience platinum-resistant and platinum-refractory relapse, the use of PLD may be acceptable because of the associated satisfactory efficacy, low frequency of AEs and high patient QOL. Moreover, a low CA125 level at baseline and a reduction in CA125 after the first cycle are predictive factors for satisfactory efficacy." @default.
- W3119274507 created "2021-01-18" @default.
- W3119274507 creator A5000703553 @default.
- W3119274507 creator A5012278873 @default.
- W3119274507 creator A5017116648 @default.
- W3119274507 creator A5024520134 @default.
- W3119274507 creator A5025463213 @default.
- W3119274507 creator A5026248787 @default.
- W3119274507 creator A5028098177 @default.
- W3119274507 creator A5028616197 @default.
- W3119274507 creator A5029633003 @default.
- W3119274507 creator A5035998127 @default.
- W3119274507 creator A5042973046 @default.
- W3119274507 creator A5044923347 @default.
- W3119274507 creator A5046238628 @default.
- W3119274507 creator A5058165407 @default.
- W3119274507 creator A5060071396 @default.
- W3119274507 creator A5060185369 @default.
- W3119274507 creator A5061707266 @default.
- W3119274507 creator A5062442867 @default.
- W3119274507 creator A5068588368 @default.
- W3119274507 creator A5076705744 @default.
- W3119274507 date "2021-01-11" @default.
- W3119274507 modified "2023-09-29" @default.
- W3119274507 title "Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer" @default.
- W3119274507 cites W1019079090 @default.
- W3119274507 cites W146281208 @default.
- W3119274507 cites W1543697093 @default.
- W3119274507 cites W1853779534 @default.
- W3119274507 cites W1910585037 @default.
- W3119274507 cites W1913802169 @default.
- W3119274507 cites W1967715255 @default.
- W3119274507 cites W1968187769 @default.
- W3119274507 cites W1990480133 @default.
- W3119274507 cites W2029409133 @default.
- W3119274507 cites W2041142804 @default.
- W3119274507 cites W2043276557 @default.
- W3119274507 cites W2067361585 @default.
- W3119274507 cites W2067985851 @default.
- W3119274507 cites W2096593771 @default.
- W3119274507 cites W2106555579 @default.
- W3119274507 cites W2107457010 @default.
- W3119274507 cites W2108090432 @default.
- W3119274507 cites W2122624385 @default.
- W3119274507 cites W2125064537 @default.
- W3119274507 cites W2128868545 @default.
- W3119274507 cites W2133506440 @default.
- W3119274507 cites W2134947875 @default.
- W3119274507 cites W2139248078 @default.
- W3119274507 cites W2150683293 @default.
- W3119274507 cites W2155126523 @default.
- W3119274507 cites W2171318838 @default.
- W3119274507 cites W2317923729 @default.
- W3119274507 cites W2528523319 @default.
- W3119274507 cites W2528622144 @default.
- W3119274507 cites W2541390219 @default.
- W3119274507 cites W2608160693 @default.
- W3119274507 cites W2728169914 @default.
- W3119274507 cites W2748207273 @default.
- W3119274507 cites W2755052350 @default.
- W3119274507 cites W2755778068 @default.
- W3119274507 cites W2772815803 @default.
- W3119274507 cites W2781525129 @default.
- W3119274507 cites W2794293350 @default.
- W3119274507 cites W2886354380 @default.
- W3119274507 cites W2935962222 @default.
- W3119274507 cites W2974337637 @default.
- W3119274507 cites W2974866787 @default.
- W3119274507 cites W4240540248 @default.
- W3119274507 doi "https://doi.org/10.1186/s13048-020-00736-2" @default.
- W3119274507 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7798203" @default.
- W3119274507 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33423683" @default.
- W3119274507 hasPublicationYear "2021" @default.
- W3119274507 type Work @default.
- W3119274507 sameAs 3119274507 @default.
- W3119274507 citedByCount "9" @default.
- W3119274507 countsByYear W31192745072021 @default.
- W3119274507 countsByYear W31192745072022 @default.
- W3119274507 countsByYear W31192745072023 @default.
- W3119274507 crossrefType "journal-article" @default.
- W3119274507 hasAuthorship W3119274507A5000703553 @default.
- W3119274507 hasAuthorship W3119274507A5012278873 @default.
- W3119274507 hasAuthorship W3119274507A5017116648 @default.
- W3119274507 hasAuthorship W3119274507A5024520134 @default.
- W3119274507 hasAuthorship W3119274507A5025463213 @default.
- W3119274507 hasAuthorship W3119274507A5026248787 @default.
- W3119274507 hasAuthorship W3119274507A5028098177 @default.
- W3119274507 hasAuthorship W3119274507A5028616197 @default.
- W3119274507 hasAuthorship W3119274507A5029633003 @default.
- W3119274507 hasAuthorship W3119274507A5035998127 @default.
- W3119274507 hasAuthorship W3119274507A5042973046 @default.
- W3119274507 hasAuthorship W3119274507A5044923347 @default.
- W3119274507 hasAuthorship W3119274507A5046238628 @default.
- W3119274507 hasAuthorship W3119274507A5058165407 @default.
- W3119274507 hasAuthorship W3119274507A5060071396 @default.
- W3119274507 hasAuthorship W3119274507A5060185369 @default.
- W3119274507 hasAuthorship W3119274507A5061707266 @default.
- W3119274507 hasAuthorship W3119274507A5062442867 @default.
- W3119274507 hasAuthorship W3119274507A5068588368 @default.
- W3119274507 hasAuthorship W3119274507A5076705744 @default.